ISPE Nordic, Denmark Yves Scholler SKAN AG

Similar documents
FDA s Guidance for Industry

FlexAct BT (Bag Tester) Flexboy 2D November, 2015

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

Overview of a sterility assurance program for PET drugs

This compilation of the complex

Aseptic Process Validation

Tests to Support Sterility Claim. Imtiaz Ahmed

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS

Review Validation of aseptic processes for pharmaceuticals

Study Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.

Isolator Technology Workshop Engineering - Validation - Operation

Validation of Sterilizing Grade Filters

Your partner in the pharmaceutical industry

BREAK WITH TRADITION LEAK DETECTION METHODS FOR PHARMACEUTICAL BLISTER PACKS. Philip Stevenson M.Eng (Hons), Product Manager, Sepha Ltd.

Julie Roberts. Audit hot Topics and Regulatory Requirements

GUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS

Compounding Aseptic Isolators (CAI) James T Wagner

MICROBIOLOGICAL CULTURE MEDIA

Inspections, Compliance, Enforcement, and Criminal Investigations

Microbiological Consideration for Non-Sterile Pharmaceutical

Insulin Syringes ACCU-SHOT TM ACCU-SHOT U40 & U100. (with Ultra Thin & Short Needle) Sizes. Colour Code of Top Cap ml U G 6 mm Red

Microbiological Cleaning Method Validation

VPA 8 Status: October 2014 Test Certificates. Containers made of plastic with bung hole or removable lid 4. Fibre drums 5

Thermoforming packaging machine R 145 with MULTIVAC Clean Design. Maximum process reliability and cleanroom suitability

PhEn-602 Notes # 4 J. Manfredi

Field Determination of Water Penetration of Windows using Blowerdoor and Infrared Camera

USP <797> Compliance Common Challenges and Potential Solutions

MEASURE FOR MEASURE: QUALITY METRICS

Cell Culture Flasks DATA SHEET

Managing Aseptic Interventions

USP <1116> and Contamination

ISPE Aseptic Conference February 2014 Washington, D.C.

INNOVATIVE PLASTIC CONTAINERS

Biological Indicators and H 2 O 2 Decontamination of Isolator Systems. Volker Sigwarth Skan AG Switzerland. Process Development

for IND and RDRC Regulated PET Compounding

Visible Particles: Regulatory and Compendial Requirements

PDA: A Global. Association. Matrix Approach to Media Fills. (c) 2012 Catalent Pharma Solutions. All rights reserved.

ISO Part 1 and Part 2 Compliance Requirements. Cathriona O Neill

ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs

Guidelines for Process Validation of Pharmaceutical Dosage Forms

GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION

ADCs: Requirements in terms of GMP and occupational safety

The Parenteral Drug Association

Tetra Pak Aseptic Package Integrity. Mike Bolstridge Director Product Quality and Safety IFTPS March 2012

Process Validation Lifecycle Approach: A Return to Science

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

Cleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products

Particulate Matter and Visual Inspection: Industry Trends 2015

Erin Patton, MS Senior Product Specialist Charles River Labs, Microbial Solutions

BSL3 and BSL4 Autoclaves. Laboratory Line

Your Goal is Zero Positives. So is Ours.

Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology

UNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS

Aseptic Processing Current Issues & Trends

Technical data pag SANITARY LINE. Small cabinets QSD pag. 3. Small cabinets QSE pag. 5. Accessories for Sanitary Line pag. 7

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

Purpose of GMP. The Underlying Principle. Why Media Fill? :Session 2: Qualification/validation of aseptic techniques dos and don ts 7/5/2014

Flexboy 2D Pre-designed Solutions for Storage Best Performance, Assurance of Supply and Closure Integrity for All Process Steps

Creating a Culture of Data Integrity Using an Automated Detection and Enumeration Method

STERIS FINN-AQUA Pure Steam Generator for Pharmaceutical Manufacturing

Model BF 260 Incubators Avantgarde.Line with forced convection

Aseptic Techniques. A. Objectives. B. Before coming to lab

HardyVal TM CSP MEDIUM-RISK LEVEL MEDIA-FILL CHALLENGE KITS

HardyVal TM CSP RANDOM TEST KIT

MICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL

Media Fill A Process Simution. Presented By Shikha Chauhan

Metrics in Microbiology Monitoring Practices

Meeting the challenges of medical device packaging

Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS

Non Destructive Inspection Technology for Thermal Power Plants

Primary Packaging change: Switch from a lyophilisate in vial to a lyophilisate in double chamber cartridge

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

PACKAGE TESTING AND VALIDATION SERVICES

PACKAGE TESTING & VALIDATION IN THIS SECTION EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

Guidelines for QualiTru Line Sampling

SEALING SOLUTIONS FOR THE PROCESS INDUSTRY

Validation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges

CERTIFICATE OF ACCREDITATION

3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally

Study disproves misconception about contamination of sterile IPA bottles.

Technical Report No. 61 Steam In Place

Packaging Form Comparison:

Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite

MINIMUM REQUIREMENTS FOR A VENDOR

RN Optical Termination Panel (RN OTP)

Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production

SCHOTT Pharmaceutical Packaging. Dedicated to quality pharmaceutical packaging

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

Hygienic Design Survival Techniques Joe Stout Commercial Food Sanitation

The biopharmaceutical industry

STERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation

ENDOSCOPIC REPROCESSING ETD DOUBLE Advancing the Efficiency of Reprocessing.

SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Process Validation Guidelines. by Pramote Cholayudth Thai Industrial Pharmacist Association (TIPA)

Transcription:

Risk of contamination through pinholes in gloves and how to prove the integrity ISPE Nordic, Denmark Yves Scholler SKAN AG 07.10.2015 1

Agenda 1 Regulatory Requirements 2 Overview of Different Testing Methods 3 Microbial contamination risk of leaky gloves 4 Requirements for a Modern Glove Testing Unit 5 Conclusion 2

Regulatory Requirements 3

Regulatory Requirements PIC/S (Aseptic processing isolators) A program to minimize the risk of loss of integrity of gloves, sleeves and suits should be present. This should include operator practices, vigilance and the absence of sharp edges. 4

Regulatory Requirements FDA (Sterile drug products produced by aseptic processing) A breach in glove integrity can be of serious consequences. A breach of isolator integrity should normally lead to a decontamination cycle. Integrity can be affected by.. holes in gloves.. or other leaks. Breaches in integrity should be investigated. If it is determined that the environment may have been compromised, any product potentially impacted by the breach should be rejected. 5

Regulatory Requirements FDA (Sterile drug products produced by aseptic processing) A fault glove or sleeve (gauntlet) assembly represents a rout of contamination and a critical breach of isolator integrity. With any use gloves should be visually evaluated for any macroscopic physical defect. Physical integrity tests should be performed routinely. The monitoring and maintenance program should identify and eliminate any lacking integrity. 6

Regulatory Requirements FDA (Sterile drug products produced by aseptic processing) Due to the potential for microbial migration to microscopic holes in gloves and the lack of highly sensitive glove integrity tests, we recommend affording attention to the sanitary quality of the inner surface of the installed glove and to integrate the use of a second pair of glove. 7

Regulatory Requirements USP 30*<1208> validation of isolator systems Gloves are another likely source of microbial contamination. Very small leaks in gloves are difficult to detect until the glove is stretched during use. There are several commercially available glove leak detectors; the operator ensures that the detectors test the glove under conditions as close as possible to actual use conditions. Microbiological tests are used to supplement or substitute physical tests. *U.S. Pharmacopeia 8

Different Testing Methods Overview Background Cooperation of Novartis Pharma AG and SKAN AG Diploma Thesis of Angela Gessler Followed by additional evaluation and studies finalized in 08/2005 9

Content of the Study Comparison of different physical methods for glove integrity testing Realistic bioload of gloves used during routine work on isolator Microbial contamination risk of leaky gloves used during routine work on isolators A founded rational for justification of the impact of a leaky glove on product during routine production and testing Published 2011, PDA Vol. 65 no. 3 10

Materials and Methods Gloves Specification: Material Hypalon Thickness 0.4 [mm] 11

Materials and Methods Measurement of Material Thickness [mm] Specified value: 0.4 [mm] Mean value and range out of 12 samples Specification: Material Hypalon Thickness 0.4 [mm] 12

Materials and Methods Definition of leak positions Selection based on: Position with frequent leaks during production Position of thin glove material Position with a high risk of contamination 13

Materials and Methods Preparation of Leaks Leaks prepared using syringe needles Ø = 0.4 [mm] Ø = 0.6 [mm] Ø = 0.8 [mm] 3 gloves prepared per position and leak Ø 3 additional tight gloves as reference 14

Materials and Methods Leak Preparation Performed with needles of diameter 0.4 / 0.6 / 0.8 mm 15

Materials and Methods Resulting leak size microscopically measured and investigated Performed with needles of diameter 0.4 / 0.6 / 0.8 mm 16

Physical Tests Comparison of different physical methods for glove integrity testing Capability of reliable detection of glove leakage Quantitative or qualitative detection of leak size Selective or cumulative detection of leak position Suitability for routine use prior production / during production 17

Physical Tests Comparison of different methods Observed water droplets are used to justify the glove integrity 18

Physical Tests Water Test 19

Physical Tests Comparison of different physical methods 20

Physical Tests Pressure drop test Measured pressure drop is used to justify the glove integrity Flow test Measured flow is used to justify glove integrity 21

Visual Testing Methods The detection of pinholes is performed visually by: Trained operator Not trained operator 22

Leak detection (%) Overview Testing Methods Leak detection / Suitability for routine use 100 90 80 70 Water test Particle test Ammonia test Peracid test Flow test Visual test (trained operator) 60 50 40 30 Helium test Visual test (done by untrained operator) Pressure drop test 20 10 0 0 2 4 6 8 10 Suitability for routine use (0=bad, 10=good) 23

Summary Physical methods All suitable physical methods show limitations in leak detection Weak point of detection are in general leaks in finger tips Trained operators are able to detect almost every leak by visual inspection 24

Microbiological Tests Microbiological growth penetration through leaky gloves Evaluation of realistic bioload on gloves used during routine production Determination of achieved Bioload Process simulation tests by handling in a isolator using leaky gloves 25

Growth penetration Test preparation Glove, glass bottle and growth media steam sterilized Transferred into decontaminated isolator system Concentration: 1.6 x 10^8 [cfu/ml] Incubation time: 14 [days] Growth evaluation: 2, 7, 14 [day] 26

Growth penetration Results Growth Penetration 27 gloves with defined leaks and 3 tight gloves All tight gloves show no growth penetration 24 leaky gloves show penetration after 2 days 26 leaky gloves show penetration after 7 days All leaky gloves show penetration after 14 days Tight gloves are a good barrier for microbial penetration All defined test leaks represent a microbial contamination risk 27

Realistic Bioload Determination of realistic Bioload on existing Production Systems 5 x production isolators surrounding room, Class D 2 x sterility test isolators surrounding room, unspecified but controlled Determination of current Bioload Determination of Bioload after disinfection 70 [%] Isopropanol, sprayed Determination of Bioload after 11 production batches ca. 45 [days] 28

Realistic Bioload 29

Realistic Bioload Bioload on existing Production Systems 30

Realistic Bioload Bioload on existing Production Systems Sample plate=25 cm^2 max. glove contamination per cm^2 =3 31

Glove contamination Determination of achieved bioload Different concentrations of test suspension 1.0x10^8 to 1.0x10^2 Glove surface fully dipped into test suspension Determination of bioload on 1 [cm^2] glove material After defined time intervals 0, 2, 4, 6 [h] 32

Glove contamination Results: Achieved Bioload per cm^2 33

Realistic Bioload Selected Contamination Levels / Bioload high bioload suspension 10^8 bioload 3 x 10^4 lower bioload suspension 10^7 bioload 4 x 10^3 realistic bioload suspension 10^4 bioload 5 x 10^1 34

Process simulation Test Preparation Defined gloves installed on isolator system Needed test material transferred into isolator system Isolator H2O2 decontaminated Start contamination of gloves 35

Process simulation Glove Contamination Each day prior testing Outer glove surface fully dipped into defined test suspension 5 [min] drying phase Start test handling 36

Process simulation Test Handling During each test period, daily Handling of 20 sterile glass balls using the contaminated gloves From left to right and from right to left 2 hours per day Over a 5 days period 37

Process simulation Contamination Control of Glass Balls Daily after each test period 4 of the glass balls transferred into growth media 2 into TSB for aerobic bacteria and molds 2 into FTM for anaerobic + aerobic bacteria Incubated period 7 [day] Growth / No Growth Evaluation 38

Process simulation Environmental Controls Daily after each test period using contact plates Finger tip of each glove Sleeve of each glove Bottom of isolator chamber Side wall of isolator chamber Daily during each test period using two settling plates Air born contamination Daily after each test period using swabs The defined leak position 39

Process simulation Results: Glove: F 0.4; Suspension: 10^8; Bioload: 3 x 10^4 40

Overview Bio Contamination Picture: SKAN 41

Summary Microbiological tests Micro-organisms are in general able to penetrate glove leaks High bioload leads to contamination of the isolator through glove leaks Lower bioload and bioload in range of realistic value shows no contamination risk 42

Conclusion Routine program for glove integrity testing Physical integrity test using pressure drop or flow test after production and change of gloves Additional visual glove inspection after physical testing Establish operator training and qualification for visual inspection Defined disinfection program to control bioload on outer glove surface Use of second pair of glove to control bioload on outer surface 43

Glove Integrity Insurance Physical testing Environmental monitoring program Maintenance - periodical changes of gloves Glove Quality Visual testing by trained personel Bio burden control = 2nd glove + desinfect 44

Requirements for a Testing Unit Short testing cycle Not sensitive against surrounding influences Fast preparation-, stabilisation- and testing phase Flexible system (e.g. recipes ) Wide and adjustable pressure range parameter (pneumatic gasket / gloves) Wireless RFID technology (e.g. automatic port detection) User friendly Clean room conform 45

WirelessGT 46

Features of the WirelessGT Completely autonomous, no cables, no wires Wireless transmission to PC Safe recognition of the tested glove port by RFID Testing time from 15 minutes, depending on glove material and accuracy required Specific test recipes for different types of gloves 47

Features of the WirelessGT User friendly operation, cgmp compliant testing Detects holes larger than 150 µm Test pressure up to 3500 Pa All gloves of an isolator can be tested simultaneously In situ testing without removal of the gloves Generates a Batch and Configuration Report 48

Wireless Glove Tester 49

1 20 39 58 77 96 115 134 153 172 191 210 229 248 267 286 305 324 343 362 381 400 419 438 457 476 495 514 533 552 571 590 609 628 647 666 685 704 723 742 761 Pascal Features of the WirelessGT 2500 Pa Measurement phase (decision phase) Pressurization phase Stabilization phase Plateau phase 100 200Pa Time 0Pa Picture: SKAN WirelessGT 50

Features of the WirelessGT 51

Conclusion A program to minimize the risk of loss of integrity of gloves should be present. Visual inspection is still the most reliable glove testing method. Appropriate complementary physical test methods (regulatory) are pressure drop or flow test. Bio-contamination is - with minor leakage of a glove not to be expected at GMP compliant application 52

WirelessGT An important contribution Physical Testing with WGT Environmental monitoring program Maintenance - periodical changes of gloves Glove Quality Visual testing by trained personel Bio burden control = 2nd glove + desinfect 53

Thank you! Questions? Yves Scholler, Sales Manager SKAN AG, Binningerstr. 116 CH-4123 Allschwil yves.scholler@skan.ch Tel +41 61 485 44 44 54